Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
The derivation of a flavonol is crucial for its application in healthcare and the food industry. Here, we provide a detailed protocol for the biosynthesis of a flavonol from a flavanone and discuss the crucial steps and its advantages over other approaches.
Flavonols are a major subclass of flavonoids with a variety of biological and pharmacological activities. Here, we provide a method for the in vitro enzymatic synthesis of a flavonol. In this method, Atf3h and Atfls1, two key genes in the biosynthetic pathway of the flavonols, are cloned and overexpressed in Escherichia coli. The recombinant enzymes are purified via an affinity column and then a bienzymatic cascade is established in a specific synthetic buffer. Two flavonols are synthesized in this system as examples and determined by TLC and HPLC/LC/MS analyses. The method displays obvious advantages in the derivation of flavonols over other approaches. It is time- and labor-saving and highly cost-effective. The reaction is easy to be accurately controlled and thus scaled up for mass production. The target product can be purified easily due to the simple components in the system. However, this system is usually restricted to the production of a flavonol from a flavanone.
Flavonols are a major subclass of plant flavonoids and are involved in plant development and pigmentation1,2,3. More importantly, these compounds possess a wide range of health-beneficial activities, such as anti-cancer4,5, anti-oxidative6, anti-inflammatory7, antiobesity8, anti-hypertensive9, and memory recall properties10, leading to a large number of studies on these plant-derived secondary metabolites. Traditionally, these compounds are mainly derived from plant extraction using organic solvents. However, due to their very low contents in plants11,12,13, the production cost for most flavonols remains high, which imposes great restrictions on their application in healthcare and the food industry.
During the past decades, scientists have developed quite a number of methods to derive flavonoids14,15. However, chemical synthesis of these complicated molecules possesses a variety of intrinsic disadvantages16. It requires not only toxic reagents and extreme reaction conditions, but also many steps to produce a target flavonoid compound14,17. Moreover, another important challenge in this strategy is the chiral synthesis of active flavonoid molecules. Therefore, it is not an ideal strategy to produce flavonoids at a commercial scale via chemical synthesis16,17.
Recently, scientists have developed a promising alternative strategy to produce these complicated natural compounds by engineering microbes with a pathway for flavonoid biosynthesis18,19,20,21,22, which has been successfully deciphered in plants23. For example, Duan et al. introduced a biosynthetic pathway into the budding yeast Saccharomyces cerevisiae to produce kaempferol (KMF)24. Malla et al. produced astragalin, a glycosylated flavonol, by introducingflavanone 3-hydroxylase (f3h), flavonol synthase (fls1), and UDP-glucose:flavonoid 3-O-glucosyltransferase UGT78K1 genes into Escherichia coliBL21(DE3)17. Even though there are quite a few paradigms, not all genetically engineered microbes produce the products of interest due to the complexity of a cellular platform, the incompatibility between artificially synthesized genetic elements and hosts, the inhibitory effect of target products against host cells, and the instability of an engineered cellular system itself16.
Another promising alternative strategy for flavonoid production is to establish a multienzymatic cascade in vitro. Cheng et al. have reported that enterocin polyketides can be successfully synthesized by assembling a complete enzymatic pathway in one pot25. This cell-free synthetic strategy circumvents the restrictions of a microbial production factory and thus is feasible for producing some flavonoids in large quantity16.
Recently, we have successfully developed a bienzyme synthetic system to convert naringenin (NRN) into KMF in one pot16. Here, we describe this system in great details and the methods involved in analyzing the products. We also present two examples that use this system to produce KMF from NRN and quercetin (QRC) from eriodictyol (ERD). In addition, we discuss crucial steps of this method and future research directions in the biosynthesis of flavonoids.
Access restricted. Please log in or start a trial to view this content.
1. Isolate total RNA from plant tissues26,27
2. Synthesize complementary DNA (cDNA)28
Reagents | Volume |
dNTP Mix, 2.5mM each | 4.0 μL |
Primer Mix | 2.0 μL |
RNA Template | 1.0 μg |
Reverse Transcriptase Buffer, 5× | 4.0 μL |
Reverse Transcriptase, 200 U/μL | 1.0 μL |
RNase-Free H2O | up to 20.0 μL |
Table 1: Reverse transcription of total RNA into cDNA
3. Construct recombinant plasmids29
Sequence, 5' → 3' | Purpose |
AAGGATCCATGGCTCCAGGAACTTTGACT | Forward primer for PCR amplification of Atf3h gene from Arabidopsis thaliana. BamHI site is italicized and attached for cloning into pET32a(+). |
AAGAATTCCTAAGCGAAGATTTGGTCGA | Reverse primer for PCR amplification of Atf3h gene from A. thaliana. EcoRI site is italicized and attached for cloning into pET32a(+). |
AAGGATCCATGGAGGTCGAAAGAGTCCA | Forward primer for PCR amplification of Atfls1 gene from A. thaliana. BamHI site is italicized and attached for cloning into pET32a(+). |
AAGAATTCTCAATCCAGAGGAAGTTTAT | Reverse primer for PCR amplification of Atfls1 gene from A. thaliana. EcoRI site is italicized and attached for cloning into pET32a(+). |
Table 2: Oligonucleotide primers used in the current study
Reagents | Volume |
Pfu Master Mix, 2× | 50.0 μL |
Forward Primer, 10 μM | 4.0 μL |
Reverse Primer, 10 μM | 4.0 μL |
cDNA | 2.0 μL |
H2O | 40.0 μL |
Table 3: Setting up of a PCR reaction system
Reagents | Volume |
DNA Fragment/Vector | 3.0 μg |
BamHI | 1.0 μL |
EcoRI | 1.0 μL |
Cutsmart Buffer, 10× | 5.0 μL |
H2O | up to 50.0 μL |
Table 4: Double digestion of a DNA fragment/vector
Reagents | Volume |
Insert | X μL (0.09 pmol) |
Vector | Y μL (0.03 pmol) |
Ligation Buffer, 10× | 1.0 μL |
T4 DNA Ligase, 400 U/μL | 1.0 μL |
H2O | up to 10.0 μL |
Table 5: Ligation of a gene fragment into a linearized vector
4. Express recombinant enzyme proteins30
5. Purify the recombinant enzyme proteins31
6. Produce a flavonol from a flavanone in an in vitro bienzyme synthetic system16
Reagents | Volume |
2× Synthetic Buffer without ferrous sulfate | 50.0 μL |
25 mM flavonol | 2.0 μL |
2 mM ferrous sulfate | 0.5 μL |
1 mg/mL AtF3H | 2.5 μL |
1 mg/mL AtFLS1 | 2.5 μL |
25 mM flavanone | 2.0 μL |
H2O | up to 100.0 μL |
Table 6: The synthetic system used in this protocol.
7. Analyze the reaction products
Access restricted. Please log in or start a trial to view this content.
F3H and FLS1 are two important key enzymes in the conversion of a flavanone into a flavonol in plants as shown in Figure 1. To develop an in vitro biosynthetic system for producing a flavonol from a flavanone, Atf3h (GenBank accession no.NM_114983.3) and Atfls1 (GenBank accession no. NM_120951.3) genes were cloned from the seedlings of 4-week-old A. thaliana into a prokaryotic expression vector pET-32a(+). The recombinant plasmids w...
Access restricted. Please log in or start a trial to view this content.
Quite a number of studies are focused on the derivation of flavonols due to their potential application in health care and food industry. However, traditional plant extraction using organic solvents and chemical synthesis possess intrinsic disadvantages, which restrict their use in the production of flavonols. Here, we report a detailed method for producing a flavonol from a flavanone in one pot by establishing an in vitro bienzymatic cascade. The critical steps in this protocol are: 1) obtaining pure recombinant enzymes...
Access restricted. Please log in or start a trial to view this content.
The authors declare that they have no competing financial interests.
This work was financially supported by Yangzhou University Specially-Appointed Professor Start-up Funds, Jiangsu Specially-Appointed Professor Start-up Funds, Six Talent Peaks Project in Jiangsu Province (Grant No. 2014-SWYY-016), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (Veterinary Medicine). We thank the Testing Center of Yangzhou University for HPLC and MS analyses of flavonoids.
Access restricted. Please log in or start a trial to view this content.
Name | Company | Catalog Number | Comments |
2× Pfu MasterMix | Beijing CoWin Biotech Co., Ltd | CW0717A | PCR amplification of genes with high fidelity |
Agilent 1200 Series RRLC system with an Agilent 6460 Triple Quadrupole LC/MS system | Agilent Technologies, Inc | N/A | an equipment for analysis of flavonoids by HPLC/MS |
Agilent MassHunter Workstation (version B.03.01) | Agilent Technologies, Inc | N/A | a software for collection of the data from the Agilent 1200 Series RRLC system with an Agilent 6460 Triple Quadrupole LC/MS system |
dihydrokaempferol | Sigma-Aldrich Co. LLC | 91216 | intermediate product for producing kaempferol from naringenin |
dihydroquercetin | Sichuan Provincial Standard Substance Center for Chinese Herbal Medicine | PCS0371 | intermediate product for producing quercetin from eriodictyol |
DNA Clean-up Kit | Beijing CoWin Biotech Co., Ltd | CW2301 | purification of PCR-amplified or gel-purified DNA |
eriodictyol | Shanghai Yuan Ye Biotechnology Co., Ltd. | B21160 | substrate for producing quercetin |
Escherichia coli BL21(DE3) | Beijing CoWin Biotech Co., Ltd | CW0809 | bacteria strain for expressing target genes |
Escherichia coli DH5α | Beijing CoWin Biotech Co., Ltd | CW0808 | bacteria strain for plasmid proliferation |
FreeZone 1 Liter Benchtop Freeze-Dry System | Labconco Corporation | 7740020 | an equipment for freeze-drying of flavonoids dissolved in organic solvent |
Gel Extraction Kit | Beijing CoWin Biotech Co., Ltd | CW2302 | purification of a DNA band from an agarose gel |
Gel Imaging System | Shanghai Tanon Science & Technology Co. Ltd. | Tanon- 2500 | an equipment for visualization of DNA band on an agarose gel or flavonoid spot on a polyamide TLC plate |
GenElute Plasmid Miniprep Kit | Sigma-Aldrich Co. LLC | PLN350-1KT | minipreparation of plasmids |
kaempferol | Sigma-Aldrich Co. LLC | 60010 | final reaction product and standard substance |
MassHunter Quanlitative Analysis (version B.01.04) | Agilent Technologies, Inc | N/A | a software for analysis of HPLC/LC/MS data |
NanoDrop Microvolume UV-Vis Spectrophotometer | Thermo Fisher Scientific | ND-8000-GL | an equipment for determination of DNA/RNA concentration |
naringenin | Sigma-Aldrich Co. LLC | N5893 | substrate for producing kaempferol |
Ni-IDA Agarose Resin | Beijing CoWin Biotech Co., Ltd | CW0010 | purification of His-tagged fusion proteins |
pET-32a(+) | Novagen | 69015-3 | plasmid for cloning and expressing target genes |
plasmid sequencing | GENEWIZ Suzhou | N/A | sequencing of recombinant plasmids |
primer synthesis | GENEWIZ Suzhou | N/A | synthesis of PCR primers |
quercetin | Shanghai Aladdin Biochemical Technology Co.,Ltd. | Q111273 | final reaction product and standard substance |
SuperRT cDNA Synthesis Kit | Beijing CoWin Biotech Co., Ltd | CW0741 | synthesis of the first strand of cDNA from total RNA |
T4 DNA Ligase | Thermo Fisher Scientific | EL0016 | ligation of an insert into a linearized vector DNA |
Trizol | Thermo Fisher Scientific | 15596018 | isolation of total RNA |
Vector NTI Advance | Thermo Fisher Scientific | 12605099 | a software for PCR primer design and DNA sequence analysis |
Xcalibur v2.0.7 | Thermo Fisher Scientific | N/A | a software for analysis of HPLC data |
Access restricted. Please log in or start a trial to view this content.
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone